EXPANDED ACCESS VERSUS EMERGENCY AUTHORIZATION – USE OF INVESTIGATIONAL CONVALESCENT PLASMA FOR THE TREATMENT OF PATIENTS WITH SEVERE OR LIFE-THREATENING COVID-19 Expanded vs.emergency use convalescent plasma
Main Article Content
Keywords
COVID-19, Convalescent, Plasma, FDA
Abstract
No Abstract